Advances in nanodelivery systems based on tumor-associated cell reprogramming strategies for enhanced tumor therapy
Acta Biomaterialia · 2026-06 · 216 · 51-66
DOI: 10.1016/j.actbio.2026.04.049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-06. Verfasst von Liang Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hematology, Renshou County People's Hospital, The Second People's Hospital of Meishan City, Meishan, Sichuan, 620500, Chin…. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Cellular Reprogramming, Nanomedicine. Die Arbeit nennt 157 Literaturangaben. Gefördert von: Southwest Medical University, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
Tumor-associated cells primarily comprise immune cells and stromal cells, which collectively construct tumor microenvironment (TME) through complex interactions. This environment not only accelerates tumor immune escape but also leads to chemotherapy resistance and immunotherapy failure, significantly increasing the risk of tumor progression and metastasis. Fortunately, these cells often exhibit phenotypic heterogeneity, allowing reprogramming strategies to transform their anti-tumor phenotypes into pro-tumor ones, thereby exerting beneficial regulatory effects on tumor progression. Nanodelivery systems (NDSs) offer significant advantages such as precise targeting and efficient delivery, making them crucial for implementing reprogramming strategies. Consequently, utilizing NDSs to reprogram tumor-associated cells for enhanced tumor therapy presents a promising solution. This review innovatively summarizes the fundamental roles, functional phenotypes, and diverse reprogramming strategies for immune cells and stromal cells within the TME. It then details therapeutic approaches by targeting distinct tumor-associated immune cells and stromal cells. Furthermore, it discusses the opportunities and challenges NDSs-based on reprogramming strategies to achieve cellular phenotype conversion. This review aims to advance our understanding of reprogramming tumor-associated immune or stromal cell phenotypes to enhance tumor therapy. STATEMENT OF SIGNIFICANCE: The tumor microenvironment (TME), largely orchestrated by heterogeneous populations of immune and stromal cells, is a pivotal determinant of therapeutic resistance and disease progression. Reprogramming these tumor-associated cells from pro-tumorigenic to anti-tumorigenic phenotypes represents a transformative strategy to overcome immune evasion, chemotherapy resistance, and immunotherapy failure. This review underscores the critical innovation of leveraging nanodelivery systems (NDSs) to precisely and efficiently implement such reprogramming strategies. By systematically synthesizing the roles, phenotypic states, and reprogramming approaches for key cellular components within the TME, this work provides a comprehensive framework for advancing targeted nanomedicine. It not only elucidates current therapeutic paradigms but also critically examines the prospects and challenges of integrating NDSs to achieve phenotypic conversion, thereby offering essential insights for the development of next-generation, microenvironment-focused cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology and Hematology, Renshou County People's Hospital, The Second People's Hospital of Meishan City, Meishan, Sichuan, 620500, China.
- Department of Pharmacy Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
- Analysis and Testing Center, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
- Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China; Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan 646000, China.
- Department of Pharmacy Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China; Chinese Pharmacy Laboratory, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, C…
- Department of Pharmacy Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China. Electronic address: lispringhong@126.com.
Förderung
- Southwest Medical University
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Liu, L., Liu, Y., Tan, X., Ding, K., Li, Q., Zhao, T., He, X., Liu, Z., Yang, H., Wu, M., & Li, C. (2026). Advances in nanodelivery systems based on tumor-associated cell reprogramming strategies for enhanced tumor therapy. Acta Biomaterialia, 216, 51-66. https://doi.org/10.1016/j.actbio.2026.04.049
Vancouver
Liu L, Liu Y, Tan X, Ding K, Li Q, Zhao T, et al. Advances in nanodelivery systems based on tumor-associated cell reprogramming strategies for enhanced tumor therapy. Acta Biomaterialia. 2026;216:51-66. doi:10.1016/j.actbio.2026.04.049
BibTeX
@article{Liu2026,
author = {Liu, Liang and Liu, Yilin and Tan, Xiao and Ding, Keyi and Li, Qi and Zhao, Ting and He, Xinghui and Liu, Ziyi and Yang, Hong and Wu, Mengxi and Li, Chunhong},
title = {Advances in nanodelivery systems based on tumor-associated cell reprogramming strategies for enhanced tumor therapy},
journal = {Acta Biomaterialia},
year = {2026},
volume = {216},
pages = {51--66},
doi = {10.1016/j.actbio.2026.04.049}
}
EUVIMED